Nephro Care India IPO is a book built issue of Rs 41.26 crores. The issue is entirely a fresh issue of 45.84 lakh shares.
Nephro Care India IPO opens for subscription on June 28, 2024 and closes on July 2, 2024. The allotment for the Nephro Care India IPO is expected to be finalized on Wednesday, July 3, 2024. Nephro Care India IPO will list on NSE SME with tentative listing date fixed as Friday, July 5, 2024.
Nephro Care India IPO price band is set at ₹85 to ₹90 per share. The minimum lot size for an application is 1600 Shares. The minimum amount of investment required by retail investors is ₹144,000. The minimum lot size investment for HNI is 2 lots (3,200 shares) amounting to ₹288,000.
Corporate Capitalventures Pvt Ltd is the book running lead manager of the Nephro Care India IPO, while Bigshare Services Pvt Ltd is the registrar for the issue. The market maker for Nephro Care India IPO is Ss Corporate Securities.
Refer to Nephro Care India IPO RHP for detailed information.
Nephro Care India IPO Details
| IPO Date | June 28, 2024 to July 2, 2024 |
| Listing Date | [.] |
| Face Value | ₹10 per share |
| Price Band | ₹85 to ₹90 per share |
| Lot Size | 1600 Shares |
| Total Issue Size | 4,584,000 shares (aggregating up to ₹41.26 Cr) |
| Fresh Issue | 4,584,000 shares (aggregating up to ₹41.26 Cr) |
| Issue Type | Book Built Issue IPO |
| Listing At | NSE SME |
| Share holding pre issue | 11,902,400 |
| Share holding post issue | 16,486,400 |
| Market Maker portion | 230,400 shares Ss Corporate Securities |
Nephro Care India IPO Reservation
| Investor Category | Shares Offered |
|---|---|
| QIB Shares Offered | Not more than 50% of the Net Issue |
| Retail Shares Offered | Not less than 35% of the Net Issue |
| NII (HNI) Shares Offered | Not less than 15% of the Net Issue |
Nephro Care India IPO Anchor Investors Details
Nephro Care India IPO raises Rs 11.15 crore from anchor investors. Nephro Care India IPO Anchor bid date is June 27, 2024.
| Bid Date | June 27, 2024 |
| Shares Offered | 1,238,400 |
| Anchor Portion Size (In Cr.) | 11.15 |
| Anchor lock-in period end date for 50% shares (30 Days) | August 2, 2024 |
| Anchor lock-in period end date for remaining shares (90 Days) | October 1, 2024 |
Nephro Care India IPO Timeline (Tentative Schedule)
Nephro Care India IPO opens on June 28, 2024, and closes on July 2, 2024.
| IPO Open Date | Friday, June 28, 2024 |
| IPO Close Date | Tuesday, July 2, 2024 |
| Basis of Allotment | Wednesday, July 3, 2024 |
| Initiation of Refunds | Thursday, July 4, 2024 |
| Credit of Shares to Demat | Thursday, July 4, 2024 |
| Listing Date | Friday, July 5, 2024 |
| Cut-off time for UPI mandate confirmation | 5 PM on July 2, 2024 |
Nephro Care India IPO Lot Size
Investors can bid for a minimum of 1600 shares and in multiples thereof. The below table depicts the minimum and maximum investment by retail investors and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 1600 | ₹144,000 |
| Retail (Max) | 1 | 1600 | ₹144,000 |
| HNI (Min) | 2 | 3,200 | ₹288,000 |
| Lot Size Calculator | |||
Nephro Care India IPO Promoter Holding
The company promoter is Dr. Pratim Sengupta.
| Share Holding Pre Issue | 85.02% |
| Share Holding Post Issue | 61.39% |
About Nephro Care India Limited
Incorporated in 2014, Nephro Care India Limited is a comprehensive treatment center located in Kolkata, offering a wide range of clinical and lifestyle solutions, as well as renal insufficiency treatment for patients.
Nephro Care is supported by expert doctors, experienced paramedical professionals, and a skilled management team.
Currently, the hospital provides healthcare services to approximately 900 Chronic Kidney Disease patients every month. The hospital has 5 permanent doctors, 10 visiting consultants, and 70 experienced paramedical professionals. These services are delivered from its main Salt Lake clinic, which covers an area of 5,352 square feet, and three satellite clinics located in Salt Lake (HB 113) and Chandannagar, West Bengal.
At present, Nephro Care offers the following services at its clinics:
- In-house Dialysis Unit
- Outpatient Services in areas of Nephrology, Diabetology, Cardiology, Ophthalmology and Neurology
- NABL accredited inhouse Pathology
- Inhouse Pharmacy
- Advance diagnostic facilities
- Renal Nutrition department
- Home Care
- Mukti (Lifestyle Support Program)
- Home Dialysis
As of March 31, 2024 the hospital employs 110 people in various departments.
Nephro Care India Limited Financial Information (Restated)
Nephro Care India Limited’s revenue increased by 398.84% and profit after tax (PAT) rose by 19920.41% between the financial year ending with March 31, 2023 and March 31, 2022.
| Period Ended | 31 Dec 2023 | 31 Mar 2023 | 31 Mar 2022 | 31 Mar 2021 |
| Assets | 2,029.85 | 831.11 | 462.93 | 112.84 |
| Revenue | 1,989.60 | 1,709.51 | 342.70 | 183.26 |
| Profit After Tax | 340.04 | 194.24 | -0.98 | 8.87 |
| Net Worth | 1,392.32 | 243.76 | 49.52 | 1.50 |
| Reserves and Surplus | 1,332.81 | 193.76 | -0.48 | 0.50 |
| Total Borrowing | 246.39 | 253.74 | 69.27 | |
| Amount in ₹ Lakhs | ||||
Key Performance Indicator
The market capitalization of Nephro Care India IPO is Rs 148.38 Cr.
KPI as of December 31, 2023.
| KPI | Values |
|---|---|
| ROE | 41.57% |
| ROCE | 36.56% |
| RoNW | 24.42% |
| P/BV | 8.04 |
| PAT Margin (%) | 17.22 |
Check Nephro Care India IPO Peer Comparison here.
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (Rs) | 1.63 | 2.75 |
| P/E (x) | 55.15 | 32.73 |
Note:
- The Pre IPO EPS is calculated based on Pre issue shareholding as on date of RHP and the latest FY earnings as of March 31, 2023 that is available in RHP.
- The Post Issue EPS is calculated based on the Post issue shareholding and annualized FY earnings of December 31, 2023 that is available in RHP.
Objects of the Issue (Nephro Care India IPO Objectives)
The company intends to utilize the Net Fresh Issue Proceeds for the following Objects
- Setting up of Multi Speciality Hospital in the name of “Vivacity Multi Specialty Hospital” (unit of Nephro Care) at Kolkata (Madhyamgaram), West Bengal; and
- General Corporate Expenses
Nephro Care India IPO Review (Avoid)
[Dilip Davda] The company is engaged in providing healthcare services with renal insufficiency treatment. It marked inconsistency in its net earnings for the reported periods and the sudden surge in bottom in for 9M-FY24 raise eyebrows and concern over its sustainability going forward. Based on its super annualized FY24 earnings, the issue appears aggressively priced. There is no harm in skipping this pricey bet. Read detail review…
Nephro Care India IPO Prospectus
Nephro Care India Limited Contact Details
Nephro Care India Limited
Flat No-1JC-18, 5th Floor Sec-III
Salt lake Kolkata, Bidhan Nagar Sai Complex,
North 24 Parganas -700098
Phone: +91 8017010197
Email: cs@nephrocareindia.com/
Website: https://www.nephrocareindia.com/
Nephro Care India IPO Registrar
Bigshare Services Pvt Ltd
Phone: +91-22-6263 8200
Email: ipo@bigshareonline.com
Website: https://ipo.bigshareonline.com/ipo_status.html